FDA Inspection 1198198 — Strides Pharma Science Limited

Strides Pharma Science Limited — FEI 3012448465

The FDA completed an inspection of Strides Pharma Science Limited on February 24, 2023 in Puducherry. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Puducherry (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126321 CFR 211.68(b)Computer control of master formula records
202721 CFR 211.192Investigations of discrepancies, failures
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.